|
Jan 4
|
Why Viking Therapeutics Stock Plummeted by 24% in December
|
|
Jan 3
|
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
|
|
Jan 3
|
From Davids to Goliaths: the GLP-1RA gold rush
|
|
Jan 3
|
Should You Buy the Dip on This High-Flying Stock?
|
|
Jan 2
|
VKTX Stock Loses More Than 20% in Six Months: Should You Buy the Dip?
|
|
Jan 1
|
Why Is Viking Therapeutics, Inc. (VKTX) Among the Best Multibagger Stocks to Buy Right Now?
|
|
Oct 12
|
The Ultimate Biotech Stock to Buy With $100 Right Now
|
|
Oct 10
|
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
|
|
Oct 10
|
Viking reports data from X-linked adrenoleukodystrophy trial
|
|
Oct 9
|
Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams
|
|
Oct 9
|
Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD
|
|
Oct 7
|
Viking Therapeutics, Inc. (VKTX): A Hot Stock to Buy Now
|
|
Oct 7
|
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
|
|
Oct 4
|
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
|
|
Oct 4
|
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
|
|
Oct 3
|
Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today
|
|
Oct 2
|
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
|
|
Sep 30
|
Why Viking Therapeutics Stock Topped the Market Today
|
|
Sep 29
|
Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024?
|
|
Sep 28
|
Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics
|